Company news
Plus Therapeutics, Inc. (NASDAQ:PSTV) news
Plus Therapeutics, Inc. news releases on 6ix. Latest, Jul 22, 2021: Plus Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights
Press releases — page 4
Plus Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights
July 21, 2021
Plus Therapeutics Announces DSMB Approval to Proceed into Eighth Cohort in ReSPECT™ Glioblastoma Trial
June 15, 2021
Plus Therapeutics Announces Key RNL™ Development and cGMP Drug Manufacturing Collaboration Agreements
May 3, 2021
Plus Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
April 21, 2021
Plus Therapeutics Enters Into Master Services Agreement with Piramal Pharma Solutions, a Leading Contract Development and Manufacturing Organization
March 22, 2021
Plus Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Business Highlights
February 21, 2021
Plus Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on February 22, 2021
February 10, 2021
Plus Therapeutics Completes Sixth Dosing Cohort in ReSPECT™ Glioblastoma Trial
December 14, 2020
Plus Therapeutics Announces Positive Interim Data from ReSPECT™ Phase 1 Clinical Trial in Recurrent Glioblastoma
November 18, 2020
Plus Therapeutics Announces Formation of Scientific Advisory Board
November 4, 2020
Plus Therapeutics Announces Initiation of Final Cohort of ReSPECT™ Glioblastoma Trial
October 28, 2020
Plus Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights
October 21, 2020
Plus Therapeutics Announces Brain Cancer Clinical Advisory Team
October 1, 2020
Plus Therapeutics Receives Fast Track Designation From FDA for Its Novel Glioblastoma Treatment
September 14, 2020
Plus Therapeutics Reports Second Quarter 2020 Financial and Business Results
August 9, 2020
Plus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT™ Glioblastoma Clinical Trial and Expands Trial Sites
July 27, 2020
Plus Therapeutics Announces Inducement Stock Grants
July 5, 2020
Plus Therapeutics Reports First Quarter 2020 Financial and Business Results
May 13, 2020
Plus Therapeutics Announces Patient-Focused Presentation Supporting Brain Tumor Awareness Month
May 11, 2020
Plus Therapeutics Announces Closing of Agreement To License Novel Oncology Platform
May 10, 2020
Plus Therapeutics Donates Personal Protective Equipment to Scripps Health to Confront COVID-19 Pandemic
April 5, 2020
Plus Therapeutics Announces Dr. Gregory Stein as Head of Clinical Development
March 31, 2020
Plus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
March 29, 2020
Plus Therapeutics Welcomes Two New Directors
March 11, 2020
Plus Therapeutics Appoints Chief Financial Officer
February 5, 2020
Plus Therapeutics Appoints Dr. An van Es-Johansson to Board of Directors
January 1, 2020
Plus Therapeutics Reports Third Quarter 2019 Financial and Business Results
November 13, 2019
Plus Therapeutics, Inc. Announces Closing of $15 Million Underwritten Public Offering
September 25, 2019
Plus Therapeutics, Inc. Announces Pricing Of $15 Million Underwritten Public Offering
September 22, 2019